How can greater awareness, research funding, and access to care help improve outcomes for breast cancer patients?

In this NYSE Live interview, Amber Guild, President and CEO of Susan G. Komen, discusses Breast Cancer Awareness Month, advances in breast cancer research, and the organization's ongoing efforts to improve patient outcomes through research, advocacy, education, and support services.

Guild joins NYSE Live after Susan G. Komen rang the NYSE Opening Bell in recognition of Breast Cancer Awareness Month and shares her perspective on the progress that has been made in the fight against breast cancer. While mortality rates have declined significantly over recent decades, she emphasizes that breast cancer remains one of the most significant health challenges facing women and families across the country.

A major focus of the conversation is awareness and early detection. Guild underscores the importance of routine screenings, understanding personal risk factors, and ensuring that individuals have access to the information and healthcare resources needed to identify breast cancer as early as possible.

The interview also explores disparities in healthcare access and outcomes. Guild discusses the challenges many patients face in obtaining screening, treatment, and support services, highlighting the need for greater equity across the healthcare system. She explains why addressing barriers to care remains a key priority in the effort to reduce breast cancer mortality rates.

Another key theme is research funding. Guild highlights Susan G. Komen's longstanding role in supporting scientific advancement and explains how the organization invests in promising researchers, medical institutions, and innovative programs designed to accelerate progress in breast cancer prevention, diagnosis, and treatment.

The conversation further examines emerging areas of breast cancer research. Guild discusses how scientists are increasingly focusing on disease subtypes, genetics, ancestry, and personalized approaches to treatment. These advances are helping researchers better understand the complexities of breast cancer and develop more targeted therapies.

In addition to research, Susan G. Komen continues to support advocacy, patient education, and community engagement initiatives. Guild explains how fundraising events, awareness campaigns, and community programs help expand access to critical resources while supporting the organization's broader mission.

A particularly personal aspect of the interview centers on Guild's own breast cancer journey. As a survivor, she reflects on the importance of early detection, quality care, and access to treatment. Her experience provides a unique perspective on the challenges patients face and reinforces her commitment to expanding support and opportunities for others navigating similar experiences.

Throughout the discussion, Guild shares insights on breast cancer awareness, research innovation, healthcare access, patient advocacy, early detection, survivorship, fundraising, and the ongoing effort to improve outcomes for patients and families worldwide.

Disclaimer: Informational content only. NYSE does not endorse or recommend investments, strategies, companies, products, or services discussed.

#NYSE #NYSELive #SusanGKomen #AmberGuild #BreastCancerAwarenessMonth #BreastCancerResearch #Healthcare #CancerResearch #WomensHealth #EarlyDetection #PatientAdvocacy #HealthcareInnovation